Global Intra-Uterine Contraceptive Devices, By Product Type (Hormonal IUCD, Copper IUCD), By End-User (Hospitals, Gynecology Clinics, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Trends and Forecast to 2022
Global Intra-Uterine Contrac…ve Devices Market has accounted for USD 3.5 billion in 2015 and is expected to reach USD 4.4 billion by 2022, growing at a CAGR of 3.5% in the forecasted period 2016 to 2022.
Request Sample Report: Global Intra-Uterine Contraceptive… Forecast to 2022
The global IUCD market has been segmented and analyzed on the basis of product type, end-user and geography.
On the basis of product type, the market has been segmented into copper IUCD and hormonal IUCD.
On the basis of end-user the market is segmented into Hospitals, Gynecology Clinics, and Community Healthcare.
- Advertising -
Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market shares countries such as U.S.
Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa.
Read more about the report: Global Intra-Uterine Contraceptive…d to grow at 3.5%
Global Player Operating in the Global Intra-Uterine Contraceptive Devices Market:
- Bayer HealthCare AG (A subsidiary of Bayer AG)
- DKT International
- Egemen International
- Melbea AG
- Teva Pharmaceuticals Industries Ltd.
- Actavis Plc.
- Ocon Medical Ltd.
- Pregna International Limited
- Medical Engineering Corporation SA
- SMB Corporation
- Meril Life Sciences Pvt. Ltd.
Browse Full Report: Global Intra-Uterine Contraceptive… Forecast to 2022
For more information: